Imidazo[1,2-a]quinoxalines accessed via two sequential isocyanide-based multicomponent reactions.
A novel synthetic protocol toward imidazo[1,2-a]quinoxalines has been developed. It includes two isocyanide-based multicomponent reactions sequentially introducing four diversity elements to the final products.